(Bloomberg) — The head of India’s main medical research agency said there were “major safety concerns” over Merck & Co.’s Covid-19 drug that may impede its addition to the country’s viral treatment list. Even though India’s drug regulator last week approved Merck’s molnupiravir for emergency use, Balram Bhargava, the director […]